Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly to Benefit from OSI Rejection
Lilly to Benefit from OSI Rejection
Lilly to Benefit from OSI Rejection
Submitted by
admin
on December 17, 2009 - 3:59pm
Source:
Seeking Alpha
News Tags:
Eli Lilly
OSI Pharmaceuticals
Tarceva
lung cancer
Alimta
Headline:
Lilly to Benefit from OSI Rejection
Do Not Allow Advertisers to Use My Personal information
